The mechanisms used by murine polyomavirus for intracellular migration are yet to be clarified. In this work we selectively depolymerized microtubules or actin fibers and then studied the progression of polyomavirus infection in cultured cells. Our results demonstrate that microtubule depolymerization prevents polyomavirus migration toward the nucleus and from the nucleus to the cell surface, being also involved in viral release, while disruption of the actin microfilaments appears to have no detrimental effect on the virus ability to reach the nucleus. The ultrastructural observation of polyomavirus nonenveloped particles interacting with the free end and the lateral sides of microtubules together with the coimmunoprecipitation of tubulin and viral VP-1 further supports the idea that polyomavirus intracellular migration seems to be mediated by the interaction of polyomavirus major capsid protein VP-1 with tubulin.
Introduction
Murine polyomavirus is a small, nonenveloped doublestranded DNA virus that can infect permissive mouse cells or transform nonpermissive rat cells through a complex interaction with different cellular regulators (Alberts et al., 1994; Courtneidge and Smith, 1983; Cullere et al., 1998; Dahl et al., 1998; Dawe et al., 1987; Dilworth et al., 1994; Freund et al., 1992; Glover et al., 1999) . After inoculation into newborn mice, some strains of polyomavirus induce epithelial and mesenchymal tumors Freund et al., 1987; Sanjuan et al., 2001) and it has been proposed that the tumorigenic potential of the different viral strains is directly related to its ability to disseminate in the mouse (Dubensky et al., 1991) . Thus, the mechanisms involved in polyomavirus replication and cell-to-cell spread are critical for understanding the bases of polyomavirus pathogenesis.
The murine polyomavirus receptor has been partially characterized but is still unknown (Bauer et al., 1999; Chen and Benjamin, 1997; Sanjuan et al., 1992; Stehle et al., 1994) . The entrance of polyomavirus into cells is also poorly understood. It has recently been published that caveolae are involved in polyomavirus endocytosis (Richterova et al., 2001) similarly to the mechanism used by the closely related simian virus SV-40 (Pelkmans et al., 2001 ). However, other reports proposed a different mechanism for polyomavirus entrance into the cell (Gilbert and Benjamin, 2000) .
Viral intracellular migration and budding have been extensively studied in enveloped viruses (Boulan and Sabatini, 1978; Sodeik, 2000; Sodeik et al., 1997) but much less is known about intracellular migration of nonenveloped particles such as polyomavirus. Several reports showed that the cytoskeleton plays an important role in the intracellular traffic of some viruses (Cudmore et al., 1995; Sasaki et al., 1995; Sodeik, 2000; Sodeik et al., 1997; Ward and Moss, 2001 ). In the case of polyomavirus, there are conflicting reports about the role played by actin fibers in viral intracellular traffic (Krauzewicz et al., 2000; Richterova et al., 2001) . Envelope-coated polyomavirus particles have been described to be associated with microfilaments bundles, but the significance of this finding is still unclear (Richterova et al., 2001) . In any case, the reports that focused on murine polyomavirus were limited to the early steps of viral entrance and transportation, usually not beyond 3 h postinfection (p.i.) (Pelkmans et al., 2001; Richterova et al., 2001) .
This article presents a straightforward study on the role of the cytoskeleton in murine polyomavirus traffic. The effect that selective depolymerization of microtubules or actin fibers had on viral infection was studied focusing especially on the events at 48 to 96 h p.i. Viral release was also studied. Immunocytochemistry, transmission electron microscopy, and immunoprecipitation were used in polarized and nonpolarized murine cells. The present results demonstrate that microtubules are essential for the progression of polyomavirus infection toward the nucleous and for the exit of progeny virus. Moreover, it reveals that "naked" polyomavirus particles are attached to the free end and the lateral sides of microtubules in a different way than reported in other studies. The coimmunoprecipitation of polyomavirus major capsid protein VP-1 with tubulin further supports this finding.
Results

Transmission electron microscopy (TEM) shows interaction of polyomavirus and microtubules
To study the progression of polyomavirus infection in primary BMK cells, monolayers were infected with the polyomavirus strain PTA and then harvested at 72 and 96 h p.i. and processed for TEM as described under Materials and methods. This procedure allowed several cycles of virus replication, and a large amount of cells and intracellular virus particles could be seen. During these studies, observations were made that suggested a physical interaction between viral particles and microtubules. As shown in Fig  1, nonenveloped polyomavirus particles were observed in the cytoplasm closely associated to the free end as well as along the sides of microtubules. The nature of these microtubules could be confirmed according to their size (25 nm), structure, and intracellular location and organization (Alberts et al., 1994) . Although most of the viral particles were observed associated to the free ends of microtubules, there were some other particles juxtaposed along the sides of microtubules. Many viral particles were also seen in the nuclei and also tightly attached to cell membranes (not shown).
Colchicine and nocodazole treatment prevents progression of polyomavirus infection in cell cultures
To investigate the role played by microtubules in the intracellular migration of polyomavirus, permissive cell cultures were treated with drugs that are known to selectively inhibit the microtubular network. The progression of the infection in the absence of functional microtubules was monitored by the expression of the major viral capsid protein VP-1 detected by immunofluorescence.
Subconfluent primary baby mouse kidney (BMK) cells were treated with the antimitotic drug colchicine. This drug is known to prevent the polymerization of tubulin into microtubules. Two hours after adding the drug, a marked disruption of the microtubules was evident by immunofluorescence (not shown). At this time, cells were infected with the polyomavirus strain PTA. As a control, another group of cells received no drug treatment (untreated controls) and was infected under the same conditions with the virus, while a third group of untreated cells was infected with a mock lysate. After the viral adsorption had finished, cultures were thoroughly washed with medium to remove any viral particles that were not cell bound. Fresh medium containing colchicine was added immediately to the first cell group while the control ones received regular media without any additional drug. Colchicine treatment did not reduce cell viability significantly according to the classic trypan blue dye-exclusion test. Several coverslips of the different experimental groups were fixed either prior to infection or 48 h p.i. Cells were labeled both with an antitubulin antibody to show the microtubular network and with the anti-VP-1 antibody A3 as a viral marker. VP-1 nuclear labeling of the cells that were infected with polyomavirus but were not treated with colchicine showed that one in every four cell was infected with PTA. However, colchicine-treated cells did not show any nuclear VP-1 in the immunofluorescence ( Figs. 2A-D) .
To strengthen this result, a second set of experiments was performed but this time a reversible microtubular inhibitor, nocodazole, was used. BMK cultures were treated with nocodazole 12 h prior to infection with PTA. Control cells received no drug treatment and were either infected with PTA or were mock infected as described above. More than 90% of the cells treated with nocodazole were viable according to the trypan blue test. Half of the coverslips were fixed at 48 h p.i. Then, all the remaining samples were washed to remove the nocodazole and nocodazole-free medium was added to all the plates. These cultures were incubated for additional 48 h at 37°C, when coverslips were processed for indirect immunofluorescence (IF). As shown in Figs. 2E-H, at 48 h p.i. 25% of the nocodazole-free PTA-infected cells showed positive nuclear VP-1 labeling (Fig. 2F) , while cells that received the virus and were treated with nocodazole showed no sign of infection according to the VP-1 labeling (Fig 2 G) . After removing nocodazole from the culture medium and completing another 48 h in nocodazole-free medium, the number of VP-1-positive nuclei was comparable to the untreated group (23%) without any additional input of polyomavirus (Fig 2H) . Therefore, progression of polyomavirus infection is halted by the disruption of the microtubular network caused by nocodazole but was restored when this microtubular inhibitor was removed.
BMK cells are primary epithelial cells that polarize in culture and are permissive for polyomavirus infection. The virus can also establish a productive infection in NIH 3T3, which is a continuous cell line of fibroblastic origin. To prove that polyomavirus infection relays on the integrity of the microtubular network in both epithelial and nonepithelial cells, experiments similar to the ones described above were performed but this time using NIH 3T3 cells. Furthermore, a more detailed analysis could be done using this cell type due to the relative simplicity of working with a continuous cell line. NIH 3T3 cultures that were grown on glass coverslips were treated with colchicine as described for the BMK cells and then infected with the polyomavirus strain PTA. As a control, another group of cells received no drug treatment and was infected under the same conditions, while a third group of cells was infected with a mock lysate. After a 2 h adsorption, the monolayers were thoroughly washed with culture medium to eliminate any remaining extracellular virus. Fresh medium containing colchicine was added immediately to the first cell group while the control ones received regular medium without any additional drugs. Several coverslips of the different experimental groups were taken from the dishes at 6, 18, and 48 h p.i. and fixed with methanol. These cells were processed for IFI as described above. At the same time, the monolayers were carefully scraped and the cell pellet was immediately fixed for TEM.
Colchicine-treated NIH 3T3 cells showed a remarkable disruption of the microtubules, which were replaced by masses of amorphous fluorescein-positive spots in the cytoplasm (Figs. 3D, E, and F). Untreated control cells showed a clear microtubular network (Figs. 3A, B , and C). None of the infected cells, whether they were treated with colchicine or were left untreated, showed any signs of VP-1 labeling shortly after infection at 6 h p.i. (Figs. 3A and D) . At 18 h p.i. some VP-1-positive spots were seen in the colchicine-untreated cells surrounding the nucleus (Fig. 3B ) and at 48 h p.i. 20% of the untreated infected cells had a clear nuclear labeling for VP-1, while only 1% of the colchicine-treated cells were positive for this viral protein (Figs. 3C and F). The trypan blue dye-exclusion test confirmed that colchicine treatment did not alter cell viability since more than 98% of the cells were alive. Ultrastructural analysis revealed the presence of 45 nm nonenveloped rounded particles in the nuclei after 48 h p.i. in the colchicine-free infected control cells, while no particles were detected in the colchicine-treated infected cells (data not shown).
As with the BMK cells, NIH 3T3 cells were cultured on glass coverslips and treated with nocodazole 12 h prior to infection with PTA. The control group was left untreated and infected with PTA and another group was mock infected as described above. After a 2 h adsorption, the monolayers were thoroughly washed to remove any remaining extracellular virus. Since it can be argued that not all the extracellular virus was efficiently removed with this wash step, a polyclonal serum with known neutralizing effects for polyomavirus (A3) was used to eliminate a possible contribution from any remaining extracellular virus. Cells that were initially treated with nocodazole received fresh medium containing nocodazole together with the A3 antibody.
Control infected cells received regular media with A3 antibody without any additional drug. Half of the coverslips were fixed at 48 h p.i. At the same time, samples for TEM were taken and fixed as previously described. Then, all the remaining cell cultures were thoroughly washed to remove the nocodazole and nocodazole-free medium was added to all the plates. In all cases, cells were refed with fresh medium plus A3 antibody. These cultures were incubated for additional 48 h when samples were processed for IFI and monolayers were fixed and embedded for TEM. Results showed that at 48 h p.i. cells treated with nocodazole had lost the network pattern of microtubules but, in this case, the microtubules organization centers (MTOCs) were conserved ( Fig. 4B ). At the same time point, 18% of the untreated infected control cells showed VP-1-positive nuclei ( Fig. 4E ), while only 1% of the drug-treated infected ones showed signs of viral infection. Moreover, after the nocodazole-treated cells were maintained in drug-free medium for an additional 48 h, 10% of the nuclei became positive for VP-1 (Fig. 4C ). Cell viability was higher than 98% as measured by trypan blue staining. Simultaneously, in samples that were studied by TEM, which showed that viral particles were present in the nucleus of infected nocodazole-free cells at 48 h p.i., viruses were not detected in the infected nocodazole-treated cultures. When nocodazole was removed from the cell cultures for an additional 48 h, abundant viral particles were observed in the nucleus and in the cytoplasm tightly attached to the cell endomembranes in a similar pattern as the one present in the control infected cells (not shown).
Colchicine or nocodazole do not impair cell endocytosis
It has been well established that the major effects of drugs such as nocodazole and colchicine are related to the were infected with polyomavirus PTA strain and double IFI was performed for VP-1 (rhodamine) and tubulin (fluorescein). Six hours post infection, VP-1 is absent in both untreated (A) and treated cells (D). After 18 h p.i., VP-1 could be detected in the cytoplasm surrounding the nucleus of colchicine-free PTA-infected cells (B) but was absent in colchine-treated PTA-infected cells (E). At 48 h p.i., VP-1 is present in the nucleus of infected control cells (C) but is absent in colchicine-treated PTA-infected ones (F). Colcichine treatment (D, E, and F) completely disrupts the microtubules. disruption of the microtubular network caused by these drugs. The lack of progression observed in polyomavirus infection when cells were treated with colchicine or nocodazole was probably due to the absence of functional microtubules and not to other effects that these drugs might have over the cell internalization mechanisms. To confirm this, the integrity of the cell uptake mechanisms was studied using a standard Lucifer yellow (LY) test, which is a routine test to evaluate the integrity of the cellular endocytic pathways. NIH 3T3 cell cultures were treated with colchicine or nocodazole as described before. After 2 h of colchicine treatment and 12 h of nocodazole treatment, culture media were replaced by fresh media containing inactivated LY. Cells were incubated for one additional hour and then were washed to remove extracellular LY. At this point they were fixed with standard techniques. Samples were observed with an epifluorescence microscope. All the samples showed a similar Lucifer yellow endosomal pattern whether they were treated with colchicine or nocodazole or were left untreated. This pattern showed the distribution of internalized LY as rounded, fluorescent dots in the cytoplasm (endodomes) in nocodazol or colchicine-treated cells as well as in the untreated cultures (not shown). This result indicated that the cell endocytic pathways remained functional in the presence of colchicine or nocodazole.
Nocodazole treatment inhibits the release of polyomavirus from infected cells
The experiments described above demonstrated that the indemnity of microtubules is critical for polyoma virus transport to the cell nucleus and that the cell culture treatment with colchicine or nocodazole does not impair cell endocytosis. To study if the microtubular network is also essential for the virus to leave the cell after a productive infection, we checked the release of polyoma virus into the culture media of infected cells, either treated with nocodazole or after this drug was removed. NIH 3T3 cells were cultured as described above until they had reached 60 -70% confluency. At that point, five sets of cells were treated as follows: one set was mock-infected; the second set was infected with the polyoma virus strain PTA; the third set was infected with PTA during 24 h; and then nocodazole was added and maintained until the end of the experiment; the fourth set was treated with nocodazole 12 h before viral infection and nocodazole was maintained in the culture medium during all the experiment; and the fifth set of cells was also treated with nocodazol 12 h before viral infection, nocodazole was maintained during 24 h p.i., but then it was removed and fresh medium was added. Conditions for viral adsorption, m.o.i., and cell cultures were identical as before. At 0, 24, and 72 h p.i., 1 ml of culture media from each one of the four sets of cell cultures was taken and maintained at Ϫ70°C until all samples were collected. In every time point, 1 ml of fresh medium was added to each one of the cell cultures. Then, NIH 3T3 cells were cultured onto glass coverslips placed into 60-mm plastic petri dishes as previously described and adsorbed with 0.3 ml of each one of the samples previously taken at every time point. After 2 h of adsorption, the inocula were removed and 5 ml of DMEM containing 5% fetal calf serum was added to each petri dish. Cells were incubated at 37°C with 5% CO 2 24 h, and then coverslips were fixed in methanol. VP-1 was detected by IFI as previously described and the percentage of infected cells was established in each sample.
The data in Fig. 5 indicate that when cells were infected and then incubated with nocodazol they only released very few infectious virus particles into the culture media. However, when nocodazole was removed after 24 h p.i., the viral progeny was released from the infected cells into the culture media.
Polyomavirus major capsid protein VP-1 coimmunoprecipitates with tubulin
The series of results described above suggested that polyomavirus might interact with the microtubular protein tubulin. To test this possibility, coimmunoprecipitation experiments were designed using an antitubulin monoclonal antibody followed by Western blot. Protein extracts were prepared from NIH 3T3 and BMK cells previously infected with PTA for 48 h. Mock-infected lysates were used as controls. Samples were resolved in SDS-acrylamide gels and transferred onto PVDF membranes. Westerns were performed using antitubulin or anti-VP-1 antibodies. In three independent experiments, tubulin coimmunoprecipitated with the major capsid protein VP-1 in both BMK and NIH 3T3 extracts. In another set of experiments, coimmunoprecipitation of tubulin and VP-1 was observed in BMK-infected cells at 72 and 96 h p.i. Addition of sepharose beads alone or preimmune serum to the extracts failed to immunoprecipitate any of the proteins (Fig. 6) .
Actin microfilaments depolymerization has no effect in polyomavirus infection
The possibility that the actin fibers might be of importance in polyomavirus infection was studied using cytochalasin D, which prevents polymerization of the actin microfilaments. NIH 3T3 and BMK cell cultures were treated with cytochalasin D 3 h before infection with PTA or mock infected, while control cells were infected with PTA without previous treatment with cytochalasin D. Samples were taken at 48 h p.i. and fixed using standard techniques. The pattern of viral infection was the same in both cell groups: about 25% of the cells were positive for VP-1 whether they had been treated with cytochalasin D or had been left Fig. 5 . Nocodazole prevents the passage of polyomavirus from the cell to the culture medium. NIH 3T3 cells were mock-infected (A), infected with PTA (B), infected with PTA during 24 h, and then treated with nocodazole and maintained with this drug during all the experiment (C), treated with nocodazole from 12 h before the infection with polyomavirus and nocodazole maintained during the whole experiment (D), and treated with nocodazole, infected with PTA, and then washed and fresh medium added (E). Samples of supernatants were taken at 0, 24, and 72 h p.i. and polyoma was titrated by adsorption onto NIH 3T3 cells grown on glass coverslips. Virus production is expressed as the percentage of VP-1 positive cells detected by IFI. It is clear that while nocodazole is present in the medium the release of polyomavirus from the cells is minimal, while it is remarkably increased after nocodazole was removed. It is also remarkable that the treatment with nocodazole of cells previously infected with PTA inhibits the virus release. untreated (Fig. 7) . IFI using a monoclonal antibody antiactin revealed that the microfilaments were remarkably altered in cells treated with cytochalasin D. These data showed that the role played by actin microfilaments, if any, is not crucial for viral migration.
Discussion
Although it has been well established that viral intracellular migration plays a central role in viral pathogenesis, the mechanisms used by nonenveloped viruses to move through the host cell cytoplasm remain obscure. We have studied the role of microtubules and actin fibers in the intracellular traffic of murine polyomavirus in primary polarized epithelial cells and in a continuous fibroblastic cell line. Our results demonstrated that an intact microtubular network is essential for the progression of polyomavirus infection since the virus could not reach the nucleus in cells treated with colchicine or nocodazole. The drug nocodazole is a reversible inhibitor of the microtubules that allowed us to analyze the progression of the infection once the drug was removed and the microtubular network was restored. The experiments showed that after nocodazole was removed, infection could progress. Where did the virus that established the infection after nocodazole was removed come from? Since no additional virus was added to the cells after the drug was removed and any possible contribution from extracellular virus was minimized by washing and by the addition of a neutralizing antibody to the media, progression of the infection was due to the initial input of virus many hours before. In nocodazole-treated cultures, polyomavirus did enter the cells and probably stayed in the periphery of the cytoplasm given that we have demonstrated that none of the drugs used affected the cell uptake mechanisms. Most likely, after nocodazole was removed, microtubules repolymerized allowing the virus to interact preferentially with the microtubular free ends and with their lateral sides, and in that way the virus could reach the nucleus. While the TEM studies confirmed the lack of viral infection when microtubules were disrupted, it also provided strong evidence for a physical association between the virus and the microtubular network. In this regard, BMK cell cultures infected at 72-96 h p.i. showed nonenveloped polyomavirus particles attached to the free end of microtubules. The nature of microtubules can be assumed according to their structure, shape, and cytoplasm localization. Multiple naked polyomavirus particles were observed in the free ends of microtubules located in different parts of the cytoplasm, some of them near the plasma membrane. Some classic articles have described that Fig. 6 . Coimmunoprecipitation of VP-1 and tubulin. BMK cells were infected with PTA or mock infected, then harvested at 72 and 96 h p.i. Protein extracts obtained from these cells were used for immunoprecipitation using an antitubulin antibody. Proteins were resolved in SDS-12% PAGE gels followed by Western blot. Two gels were run simultaneously and in parallel and the same samples were loaded in both of them. In one of the gels tubulin was detected using a mouse immunoglobulin antitubulin (A). In the other gel, detection of VP-1 was done using a rabbit immunoglobulin anti-VP-1 ( polyomavirus can be seen not only as 45-nm spherical structures but also as filaments. Thus, it could be argued that what we described as microtubules could have been filamentous forms of polyomavirus. We have indeed observed these images in the same cell cultures where the association between polyomavirus and microtubules was seen, but they can be easily distinguished from microtubules in that the former is located only in the nuclei, has an average shape of 45 nm and does not have the ultrastructural appearance of microtubules (not shown). Moreover, a detailed observation of the association between polyomavirus and microtubules showed a naked polyomavirus particle, then a narrow "neck", and then a structure with all the characteristic of a microtubule. We have also found polyomavirus particles surrounded by a trilaminar structure that resembled membranes as other authors have described (Richterova et al., 2001 ), but these structures were mostly associated with plasma membranes or were free in the cytoplasm. While most viral particles were associated with the free end of microtubules, some others were seen juxtaposed along the sides of microtubules. This last finding suggests the possibility that the interaction of polyomavirus with microtubules could also be mediated by the interaction with microtubules-associated motor proteins such as kinesins and dynein, located along the microtubule. To explain the presence of viral particles not associated with microtubules, two facts have to be taken into consideration. One is that it should not be necessary that all polyomavirus particles located at a certain moment in the cytoplasm of a cell infected after 72 h have to be associated with microtubules and migrate toward the nucleus or to the plasma membrane all together. The other is that an electron micrograph is a two-dimensional image of a fact that happens in a three-dimensional way. Thus, it is quite possible that the particles apparently not associated with microtubules shown in Fig 1 are indeed associated with them, but these microtubules had not been cut by the knife in the same sense as the viral particles.
Coimmunoprecipitation of tubulin and the viral major capsid protein VP-1 further confirmed the interaction between tubulin and the virus when an antitubulin serum was used. Unfortunately, we could not strengthen this result with the reciprocal reaction since none of the available anti-VP1 antibodies we have tried were successful in immunoprecipitating VP-1. Nevertheless, the images observed by TEM where polyomavirus particles are attached to microtubules, the experiments performed with drugs that selectively depolymerize microtubules and the coimmunoprecipitation of tubulin and VP-1 when an antitubulin serum was used, provided strong evidence that this association actually occurs. Moreover, coimmunoprecipitation of tubulin and VP-1 was observed in BMK cells extracts at 72 and 96 h p.i., when infectious virus release was detected in the supernatants of cells in the absence of nocodazole and when viral particles were observed associated with microtubules. Taken together, these data reinforce the hypothesis of the dependence on microtubules for virus exit.
This work demonstrated that microtubule disruption inhibits polyomavirus migration from the cell membrane to the nucleus and rules out the contribution of actin fibers in polyomavirus intracellular movement. Moreover, we were able to show that the indemnity of the microtubular network is also essential for polyomavirus to leave the cell after infection. In this regard, the results presented here establish that cells treated with nocodazole from 12 h before the infection with polyomavirus until the end of the experiment, 72 h later, released very few infectious virus into the culture media, while cell cultures where nocodazole was removed 24 h after the infection did allowed a massive passage of infectious virus to the culture media almost with the same titers observed in the cells used as a control (only infected with poliomavirus without nocodazole). However, it could be argued that this result was due to inhibition of early stages of infection by nocodazole. To clearly demonstrate that the indemnity of microtubules is necessary for virus release, in another experiment the infection of the cell cultures was done 24 h before nocodazole was added, thus allowing polyomavirus to enter the cell in the absence of any drug, and then cells were treated with nocodazole as described above. As shown in Fig. 5 , very few infectious virus were detected in the supernatant of cell cultures infected with polyomavirus and then treated with nocodazole, while a large amount of infectious virus could be recovered in the supernatant of polyomavirus-infected, nocodazol-untreated cells. This difference can only be explained by the absence or presence, respectively, of polymerized microtubules. The results presented in this work (in contrast to other studies concentrating on the early stages of infection) focused on both the early and the later stages of polyomavirus infection, including the exit of progeny virus, and demonstrate that the indemnity of the microtubular network is necessary for virus entrance to the cell and for virus release from the cell. This last point is provocative, since it proposes that polyomavirus leaves the infected cell using microtubules and not just as a consequence of cell lysis, as has been described in other nonenveloped viruses.
Polyomavirus transport is probably dependent on the interaction between the virus major capsid protein VP-1 and tubulin. A novel mechanism for polyomavirus intracellular traffic that implies a physical association between viral nonenveloped particles with the free end of microtubules is proposed, although the characterization of the molecular bases of this interaction is beyond the scope of this article. Another aspect that deserves further study is how virus actually travels using microtubules. Some of the already known microtubular motor proteins (MAPs) such as dynein and kinesins are likely to mediate microtubular-dependent viral transport (Alonso et al., 2001) . The possibility that the association to alternative MAPs might promote movement is suggested in this work by the ultrastructural observation of some polyomavirus particles attached to the sides of microtubules. The possible association between MAPs and polyomavirus in currently under investigation.
Materials and methods
Virus
The polyomavirus PTA strain used was a kind gift of Thomas L. Benjamin (Harvard Medical School, Boston, MA) . Viral stocks were produced by infecting primary baby mouse kidney cells prepared from specific pathogen-free BALB/c mice. Cells were grown in Dulbecco's modified Eagle's medium (DMEM) (Gibco) and 10% calf serum (CS) (Gibco), and then infected at a multiplicity of infection of 0.1 PFU per cell and incubated at 37°C in a 5% CO 2 atmosphere until complete cytopathic effect was observed. Cultures were harvested with a rubber policeman and sonicated three times, and cell debris was removed by centrifugation for 15 min at 400 g. The titers of the supernatants were determined on NIH 3T3 cells under agar (Turler and Beard, 1985) and then aliquoted and stored at Ϫ20°C.
Animals
BALB/c mice were obtained from the University of La Plata School of Veterinary Medicine, La Plata, Argentina and bred in pathogen-free conditions. Mice were kept five to a box and fed on pellets ad libitum.
Cell cultures
BMK cells were prepared from the kidneys of 8-to 10-day-old BALB/c mice. Kidneys were dissected under sterile conditions, cut into 1 mm pieces, and kept in DMEM-0.05 mM EDTA. After washing the kidney sections in DMEM-EDTA, the tissue suspension was incubated in DMEM-0.25 M trypsin at 37°C with continuous agitation. After 10 min the cell suspension was removed, leaving the larger tissue pieces behind. This procedure was repeated three times to allow for almost complete disaggregation of the tissue sections. Cells were then washed with fresh DMEM and 10% CS, pelleted at low speed, washed again, and pelleted in PBS. The procedure described by Vinay et al. (1981) for preparation of tubule fragments by Percoll centrifugation was followed with some modifications. The cell pellet was resuspended in a 50% isotonic Percoll mixture made from concentrated HEPES solution (136 mM NaCl, 9.4 mM KCl, 2.50 mM CaCl 2 , 2.50 mM MgSO 4 , 2.36 mM KH 2 PO 4 , 20 mM glucose, 40 mM Na cyclamate, 10 mM HEPES pH 7.40) and Percoll (Pharmacia). The F1 band was removed from the gradient and washed three times in DMEM-10% CS. Cells were then resuspended in DMEM-10% CS and passed through a sieve to minimize glomeruli contamination. The cell suspension was seeded in plastic tissue culture dishes with or without glass coverslips with DMEM-10% CS plus antibiotics (penicillin/streptomycin) and incubated at 37°C for 72 h to allow cell polarization before they were ready to use in the different experimental procedures. NIH 3T3 cells were cultured on coverslips placed in plastic tissue culture plates with DMEM-10% CS. Cultures were incubated at 37°C in a 5% CO 2 atmosphere and used when they reached 75% confluency.
Infection and drug treatments
Cells were infected using the polyomavirus PTA strain stocks (see above) at a multiplicity of infection of 0.2 PFU per cell. Viral adsorption was carried out for 2 h at 37°C in minimal volume. After adsorption, cells were washed twice with medium and fresh medium plus serum was replaced. When appropriate, cells were treated for 2 h before infection in normal medium containing 50 M colchicine (from 20 mM stock in DMSO) (Sigma) or 1 M cytochalasin D (from 10 mM stock in DMSO) (Sigma). Cells were maintained in these drugs during the entire length of the experiment. In experiments where nocodazole (Sigma) was used, cells were incubated with this drug for 12 h prior to infection at a concentration of 2 M (from 20 mM stock in DMSO) and maintained in this drug for the first 48 h p.i. A rabbit antipolyomavirus major capsid protein VP-1 with viral neutralizing activity was added to the medium at a dilution of 1:10,000. This serum called A3 was a gift of Thomas L. Benjamin (Harvard Medical School). Then monolayers were washed three times to remove the nocodazole, and fresh medium containing 10% CS was added.
Indirect immunofluorescence
Cells were grown on coverslips and fixed for 20 min in methanol and then washed with PBS and blocked with 5% normal goat serum in PBS. Cells were subjected to double immunofluorescent labeling using the A3 serum at 1:1000 dilution in PBS together with a monoclonal anti-␣-tubulin antibody (Sigma) at a 1:500 dilution in PBS. After washing thoroughly with PBS, a goat anti-rabbit immunoglobulin conjugate with rhodamine (Sigma) was added at a dilution of 1:500 together with a goat anti-mouse immunoglobulin conjugated with fluorescein (Sigma) at a 1:500 dilution in PBS. After incubating cells for 1 h in the presence of the secondary antibodies, samples were washed with PBS and mounted onto glass slides with a mix of 50% glycerol/50% PBS. Slides were observed in a Zeiss immunofluorescence microscope with epiillumination. In every experiment, 500 cells per slide were counted.
To label the actin microfilaments (Spector et al., 1998) , cell cultures grown as described above were fixed with 4% formaldehyde solution in PBS at room temperature for 20 min. Cells were then washed with 0.5 M glycine in PBS followed by permeabilization with a 30-s extraction with cold acetone. After three washes with PBS, cells were blocked as described above. Samples were subjected to double labeling using the A3 serum and a monoclonal antiactin antibody (Sigma) at a 1:200 dilution in PBS. Incubation was carried out overnight at 4°C. The incubation with the secondary antibodies was identical to the one described before. Coverslips were mounted and processed as above.
Lucifer yellow uptake
Lucifer yellow (dilithium salt, Sigma) was inactivated as described by Bomsel et al. (1989) and was added at a concentration of 10 mg/ml to serum-free medium. BMK cells grown on coverslips were incubated with inactivated LY for 60 min. Then the cells were washed three times with PBS and fixed in cold methanol (4°C) for 10 min. Coverslips were mounted on glass slides and analyzed using an epifluorescent microscope with a fluorescein filter. The same test was performed with NIH 3T3 cells.
Transmission electron microscopy
Cell monolayers were fixed in 4% formaldehyde freshly prepared from paraformaldehyde plus 1% glutaraldehyde in PBS, pH 7.4, 1 h at room temperature, and then harvested with a rubber policeman and centrifuged at 100 g for 5 min. After postfixation in 1% osmium tetroxide, cell pellets were routinely embedded in Vestopal. Slides were obtained using glass knives, and grids were stained with uranyl acetate and lead citrate. Specimens were observed in a Zeiss EM 109-T transmission electron microscope, at 80 kV.
Immunoprecipitation and western blotting
Protein extracts were prepared from cell monolayers by washing cells twice with PBS. Cells were scraped and pelleted, followed by the addition of a cold lysis buffer (50 mM Tris pH 7.4, 200 mM NaCl, 1 mM EDTA, 1 mM DTT, 1% NP-40) and by sonicating for 30 s. Extracts were cleared by centrifugation at 400 g at 4°C for 10 min.
For the immunoprecipitations, protein extracts and the appropriate antibody were incubated on ice for 1 h followed by the addition for 1 h of protein A-Sepharose (Sigma) previously washed three times in lysis buffer. The immunoconjugates were recovered by spinning and washing three times with lysis buffer. Pellets were resuspended in Laemmli sample buffer and heated at 90°C for 2 min. After cooling samples on ice for 5 min, immunoprecipitations were resolved in sodium dodecyl sulfate (SDS)-acrylamide gels. Gels were blotted onto PVDF membrane (Hy-bond Pharmacia) and incubated with TNET buffer (10 mM Tris, 3 mM EDTA, 50 mM NaCl, 1% Tween 20, pH 7.5) containing 5% nonfat dry milk. For Westerns, the A3 serum was diluted 1:10,000 and the antitubulin antibody was diluted 1:5000 and incubated for 1 h, followed by goat antirabbit immunoglobulins conjugated with 125 I (NEN, 1:10,000) or goat anti-mouse immunoglobulin conjugated with 125 I (NEN, 1:10,000). Extensive washing was performed after each incubation using TNET. Blots were developed using Kodak XAR film.
